-
Chronic drug shortages impact patient care across the United States. Our mission is to provide quality generic medicines that are available and affordable to everyone.
Member hospital teams and their patients now have reliable access to over 50 Civica medicines, including those used to help fight COVID-19.
- Civica is featured in the New England Journal of Medicine. Learn more about our "novel approach to doing business."
- From the New York Times: Our Drug Supply Is Sick. Civica is featured as a solution.
0 Million
Patients treated with Civica medications
These include:
Advocate Aurora Health
Allegheny Health Network
Aspirus Health System
Baptist Health
Baptist Health South Florida
Baylor Scott & White Health
BJC HealthCare
Christiana Care Health System
CommonSpirit Health
Cone Health
Emerson Health
Franciscan Alliance
Gary and Mary West Foundation
Griffin Hospital
Hospital Corporation of America (HCA)
Hospital Sisters Health System
Integris Health
Intermountain Healthcare
Kaiser Permanente
Kootenai Healthcare
Laura and John Arnold Foundation
Mayo Clinic
MemorialCare
Memorial Hermann
Montage Health
Memorial Sloan Kettering Cancer Center
New Hanover Regional Medical Center
NorthBay Healthcare
North Memorial Hospital
NYU Langone Health
Ochsner Health System
Peterson Center on Healthcare
Piedmont Health
Piedmont Health
ProMedica Health
Piedmont Health
Providence St. Joseph Health
Regional One Health
Reid Health
Samaritan Health Services
SCL Health
Sanford Health
SCL Health
Southeast Georgia Health System
Spectrum Health
SSM Health
St. Clair Hospital
Steward Health Care System
St. Luke's University Health Network
The Christ Hospital
ThedaCare
Trinity Health
UnityPoint Health
University of Miami Health
University of Utah Health
U.S. Department of Defense
U.S. Department of Veterans Affairs
VCU Health
Recent News
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
The new facility, part of a partnership with Virginia-based Phlow Corp., will employ more than 180 people and will help ensure a safe, stable, and affordable supply of essential generic medicines for U.S. patients. Civica will produce sterile injectable medications used in hospitals for COVID-19 patient care, emergency room and intensive-care unit treatments, surgeries,...
Civica’s Chief Commercial Officer, Heather Wall, is Named One of Utah Business Magazine’s “2020 CXO’s of the Year”
We are so proud of Civica's Chief Commercial Officer, Heather Wall, for her recognition as one of Utah Business Magazine's "2020 CXO's of the Year." Heather has been instrumental in the design of Civica from concept to today. “Heather is a force of nature - she inspires all of us with her energy, expertise...
Essential Medicines Company Civica Rx Turns 2, Marking Numerous Milestones
Launched in 2018 as a nonprofit generic drug company to address the problem of chronic drug shortages, Civica Rx (Civica, Inc) has proven to be a viable industry player, ensuring stable and predictable supplies of over 20 essential generic drugs so far, and generating millions of dollars in savings for hospitals. The brainchild of...
Why Civica?
Over the past two decades, shortages of generic, injectable drugs critical to the lifesaving work of hospitals in the United States have become commonplace. These drug shortages are so ubiquitous that hospitals and health care systems now maintain permanent drug shortage response teams that seek alternatives to unavailable drugs.
As a result, time that hospital pharmacists, technicians, nurses and others would prefer to spend caring for patients is spent ensuring that the patients who most need short-supply drugs get whatever supply is available.
Civica was created to reduce and prevent drug shortages and the price spikes that can accompany them. Its mission is to make quality generic medicines accessible and affordable to everyone.